Novo Nordisk is seeking Chinese approval for its oral weight loss pill
- Chinese: 21 events in the last 90 days
- Previous: earlier the same day · Z.ai stock surged after launching an AI model running entirely on Chinese chips
What happened
China's drug regulator accepted Novo Nordisk's application for an oral version of Wegovy as the Danish company competes with Eli Lilly in the market
Summary assembled by rule from the sources below